HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Unrelated stem cell transplantation after a reduced intensity conditioning regimen containing high-dose thymoglobulin leads to controllable graft-versus-host disease.

AuthorsJ F Lacerda, C Martins, F Lourenço, J A Carmo, C Juncal, J J G Oliveira, J M F Lacerda
JournalBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation (Biol Blood Marrow Transplant) Vol. 13 Issue 4 Pg. 494-7 (Apr 2007) ISSN: 1083-8791 [Print] United States
PMID17382257 (Publication Type: Clinical Trial, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antilymphocyte Serum
  • thymoglobulin
Topics
  • Adolescent
  • Adult
  • Antibodies, Monoclonal (therapeutic use)
  • Antilymphocyte Serum
  • Disease-Free Survival
  • Female
  • Graft vs Host Disease (prevention & control)
  • Graft vs Leukemia Effect
  • Hematopoietic Stem Cell Transplantation (adverse effects, methods)
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive (therapy)
  • Leukemia, Myeloid, Acute (therapy)
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes (therapy)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (therapy)
  • Transplantation Conditioning (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: